Portfolio company
ShanX Medtech
Netherlands · £20.4m raised
Raised
£20.4m
Latest stage
Seed
Rounds recorded
1
Backed by
5 investors
Sectors
About
The company develops rapid antimicrobial susceptibility testing diagnostics for healthcare providers to identify effective antibiotic treatments for bacterial infections in approximately one hour.
SourceFunding history · 1
Similar companies
ShanX
ShanX Medtech develops in-vitro diagnostic platforms for rapid antibiotic susceptibility testing to help clinicians treat bacterial infections in point-of-care and laboratory settings.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Astrego
This company develops automated microfluidic systems for rapid antibiotic susceptibility testing to support clinicians in diagnosing and treating bacterial infections at point-of-care settings.
iFAST
iFAST Diagnostics develops rapid antimicrobial susceptibility testing systems for hospital laboratories to identify effective antibiotics for treating bacterial infections.
Resistell
This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.
SoundCell
SoundCell develops graphene-based biosensor platforms for rapid antibiotic susceptibility testing to help healthcare professionals and diagnostic laboratories identify effective treatments for bacterial infections.
Resistell AG
Resistell AG develops rapid antibiotic susceptibility testing platforms using nanomotion technology for healthcare providers and clinical researchers to improve treatment of bloodstream infections.
Pattern Biosciences
This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.
